Edwards Lifesciences Performance

EW -- USA Stock  

USD 147.49  0.64  0.43%

Macroaxis gives Edwards Lifesciences performance score of 0 on a scale of 0 to 100. The firm shows Beta (market volatility) of -0.1005 which denotes to the fact that as returns on market increase, returns on owning Edwards Lifesciences are expected to decrease at a much smaller rate. During bear market, Edwards Lifesciences is likely to outperform the market.. Even though it is essential to pay attention to Edwards Lifesciences historical returns, it is always good to be careful when utilizing equity current trending patterns. Macroaxis philosophy towards predicting future performance of any stock is to check both, its past performance charts as well as the business as a whole, including all available technical indicators. Edwards Lifesciences Corporation exposes twenty-eight different technical indicators which can help you to evaluate its performance. Edwards Lifesciences has expected return of -0.1581%. Please be advised to confirm Edwards Lifesciences Potential Upside as well as the relationship between Kurtosis and Day Typical Price to decide if Edwards Lifesciences past performance will be repeated at some point in the near future.
 Time Horizon     30 Days    Login   to change

Edwards Lifesciences Relative Risk vs. Return Landscape

If you would invest  15,311  in Edwards Lifesciences Corporation on June 16, 2018 and sell it today you would lose (498.00)  from holding Edwards Lifesciences Corporation or give up 3.25% of portfolio value over 30 days. Edwards Lifesciences Corporation is generating negative expected returns and assumes 1.2127% volatility on return distribution over the 30 days horizon. Put differently, 11% of equity instruments are less risky than the company on the bases of their historical return distribution and some 99% of equities are expected to be superior in generating returns on investments over the next 30 days.
 Daily Expected Return (%) 
      Risk (%) 
Allowing for the 30-days total investment horizon, Edwards Lifesciences Corporation is expected to under-perform the market. In addition to that, the company is 1.83 times more volatile than its market benchmark. It trades about -0.13 of its total potential returns per unit of risk. The DOW is currently generating roughly 0.01 per unit of volatility.

Edwards Lifesciences Market Risk Analysis

Sharpe Ratio = -0.1304
Good Returns
Average Returns
Small Returns
Negative ReturnsEW

Edwards Lifesciences Relative Performance Indicators

Estimated Market Risk
  actual daily
 89 %
of total potential
Expected Return
  actual daily
 1 %
of total potential
Risk-Adjusted Return
  actual daily
 1 %
of total potential
Based on monthly moving average Edwards Lifesciences is performing at about 0% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Edwards Lifesciences by adding it to a well-diversified portfolio.

Performance Rating

Edwards Lifesciences Corporation Risk Adjusted Performance Analysis

Risk-Adjusted Performance

Over the last 30 days Edwards Lifesciences Corporation has generated negative risk-adjusted returns adding no value to investors with long positions.

Edwards Lifesciences Alerts

Equity Alerts and Improvement Suggestions
Edwards Lifesciences generates negative expected return over the last 30 days
Latest headline from MacroaxisInsider: Payment of 498 shares by Reindl Robert C of Edwards Lifesciences subject to Rule 16b-3
Additionally see Investing Opportunities. Please also try Volatility Analysis module to get historical volatility and risk analysis based on latest market data.